Search results for "Multifocal disease"

showing 3 items of 3 documents

Non-coronary atherosclerosis

2014

International audience; During the last decades, the clinical and research interest in atherosclerosis has been mostly focused on coronary arteries. After the publications of the European Society Guidelines and AHA/ACC Guidelines on Peripheral artery diseases, and of the Registry REduction in Atherothrombosis for Continued Health Registry, there has been an increased interest in atherosclerosis of the lower extremity arteries and its presence in multifocal disease. However, awareness in the general population and the medical community of non-coronary artery diseases, and of its major prognostic implications remain relatively low. The aim of this general review stemming out of an ESC Working…

Carotid Artery Diseasesmedicine.medical_specialtyPopulationAortic DiseasesComplex diseaseAorta Thoracic610 Medicine & healthDisease2705 Cardiology and Cardiovascular MedicinePeripheral artery circulationUpper ExtremityRenal ArteryMultifocal diseasemedicineHumansAorta AbdominalPeripheral Artery DiseaseseducationIntensive care medicineCoronary atherosclerosisPeripheral Vascular Diseaseseducation.field_of_studybusiness.industry10031 Clinic for AngiologySettore MED/11 - Malattie Dell'Apparato CardiovascolareMesenteric Arteries3. Good healthCoronary arteriesEarly Diagnosismedicine.anatomical_structureLower ExtremityAtherosclerosiPhysical therapy[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieperipheral artery circulation; atherosclerosisArtery diseasesatherosclerosisCardiology and Cardiovascular Medicinebusiness
researchProduct

Chemotherapy for Urinary Bladder Cancer: Developments, Trends, and Future Perspectives

1982

The role of chemotherapy in the management of transitional bladder tumors can conveniently be considered under two principal headings — topical (intracavitary) and sytemic chemotherapy, as the indications for these modalities are distinctly different. The intent of topical administration of cytoxic agents may be (1) prophylactic to prevent recurrences or new occurrences after TUR; (2) curative to clear the bladder of extensive non-resectable multifocal disease, or to control carcinoma in situ.

OncologyChemotherapymedicine.medical_specialtyUrinary bladderBladder cancerUrinary Bladder Cancerbusiness.industrymedicine.medical_treatmentCarcinoma in situmedicine.diseasemedicine.anatomical_structureMultifocal diseaseInternal medicineBladder tumorSuperficial bladder cancerMedicinebusiness
researchProduct

DIAGNOSTIC APPROACH TO THE PATIENTS WITH SUSPICION OF MULTIFOCAL DISEASE

2005

MULTIFOCAL DISEASE
researchProduct